Wilson & Boucher Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$976K Hold
2,773
0.65% 41
2025
Q4
$908K Hold
2,773
0.6% 45
2025
Q3
$783K Sell
2,773
-300
-10% -$87K 0.51% 53
2025
Q2
$858K Hold
3,073
0.6% 47
2025
Q1
$957K Hold
3,073
0.71% 40
2024
Q4
$801K Sell
3,073
-10
-0.3% -$2.97K 0.57% 50
2024
Q3
$993K Hold
3,083
0.68% 42
2024
Q2
$963K Sell
3,083
-100
-3% -$29.4K 0.74% 41
2024
Q1
$905K Sell
3,183
-380
-11% -$111K 0.71% 39
2023
Q4
$1.03M Hold
3,563
0.86% 34
2023
Q3
$958K Buy
3,563
+8
+0.2% +$2K 0.91% 32
2023
Q2
$789K Hold
3,555
0.71% 45
2023
Q1
$859K Buy
3,555
+10
+0.3% +$2.46K 0.83% 38
2022
Q4
$931K Hold
3,545
0.95% 34
2022
Q3
$799K Hold
3,545
0.93% 37
2022
Q2
$862K Sell
3,545
-200
-5% -$49K 0.95% 39
2022
Q1
$906K Buy
3,745
+100
+3% +$23K 0.82% 41
2021
Q4
$820K Buy
+3,645
New +$769K 0.74% 47

Other funds holding AMGN

Wilson & Boucher Capital Management's AMGN Position: Q1 2026 in Review

Wilson & Boucher Capital Management held its Amgen (AMGN) position steady in Q1 2026 at 2,773 shares worth $976K. The position accounts for 0.65% of the portfolio, ranked #41.

Wilson & Boucher Capital Management first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.03M in Q4 2023. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Wilson & Boucher Capital Management held 2,773 shares of Amgen worth $976K as of Q1 2026.
  • Wilson & Boucher Capital Management left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.65% of Wilson & Boucher Capital Management's portfolio in Q1 2026, its #41 holding.
  • Wilson & Boucher Capital Management first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • Wilson & Boucher Capital Management's Amgen position peaked at $1.03M in Q4 2023.
  • 3,133 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Wilson & Boucher Capital Management's 13F filing for Q1 2026, filed 18 May 2026.